| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0036 | 1 |